b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29330034</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>24</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>24</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1872-7913</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>51</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of antimicrobial agents</Title>\n                <ISOAbbreviation>Int. J. Antimicrob. Agents</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Successful treatment of a penicillin-intermediate and ceftriaxone-resistant Granulicatella adiacens presumed prosthetic valve endocarditis with vancomycin.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>508-510</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0924-8579(18)30002-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2017.12.031</ELocationID>\n            <Abstract>\n                <AbstractText>Advancements in rapid diagnostics have helped to identify nutritionally variant streptococci (NVS) as an increasing cause of infective endocarditis (IE). This case report highlights the challenges in susceptibility testing and the importance of appropriate empiric treatment for Granulicatella adiacens, and provides considerations for future practice guideline recommendations. Guidelines for treatment of IE caused by NVS are currently limited to patients with native valve disease. We present a patient with presumed prosthetic valve endocarditis caused by G. adiacens, with clinically relevant resistance to recommended first-line agents (penicillin and ceftriaxone), who was successfully treated with 8 weeks of intravenous (IV) vancomycin. Vancomycin is currently recommended as an alternate therapy for patients intolerant of penicillins, but we believe vancomycin should be considered a first-line empiric treatment option for IE when the identified organism is G. adiacens and susceptibility testing is not readily available.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Jones</LastName>\n                    <ForeName>Bruce M</ForeName>\n                    <Initials>BM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>St. Joseph\'s/Candler Health System, Inc., 5353 Reynolds Street, Savannah, GA 31405. Electronic address: jonesbru@sjchs.org.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hersey</LastName>\n                    <ForeName>Roby M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>St. Joseph\'s/Candler Health System, Inc., 5353 Reynolds Street, Savannah, GA 31405.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Trestman</LastName>\n                    <ForeName>Irwin J</ForeName>\n                    <Initials>IJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>St. Joseph\'s/Candler Health System, Inc., 5353 Reynolds Street, Savannah, GA 31405.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bland</LastName>\n                    <ForeName>Christopher M</ForeName>\n                    <Initials>CM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>University of Georgia College of Pharmacy, St. Joseph\'s/Candler Health System, Inc., Savannah, GA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D002363">Case Reports</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>09</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>Int J Antimicrob Agents</MedlineTA>\n            <NlmUniqueID>9111860</NlmUniqueID>\n            <ISSNLinking>0924-8579</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010406">Penicillins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>6Q205EH1VU</RegistryNumber>\n                <NameOfSubstance UI="D014640">Vancomycin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>75J73V1629</RegistryNumber>\n                <NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D056568" MajorTopicYN="N">Carnobacteriaceae</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004697" MajorTopicYN="N">Endocarditis, Bacterial</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016908" MajorTopicYN="N">Gram-Positive Bacterial Infections</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010406" MajorTopicYN="N">Penicillins</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016459" MajorTopicYN="N">Prosthesis-Related Infections</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014640" MajorTopicYN="N">Vancomycin</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018440" MajorTopicYN="N">beta-Lactam Resistance</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Granulicatella adiacens</Keyword>\n            <Keyword MajorTopicYN="N">Infective endocarditis</Keyword>\n            <Keyword MajorTopicYN="N">Nutritionally variant streptococci (NVS)</Keyword>\n            <Keyword MajorTopicYN="N">Prosthetic valve endocarditis</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29330034</ArticleId>\n            <ArticleId IdType="pii">S0924-8579(18)30002-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ijantimicag.2017.12.031</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'